Rodríguez CCE, González FC, Garcés HMJ, Cota AJM, Von BFA

Idioma: Español
Referencias bibliográficas: 19
Paginas: 241-244
Archivo PDF: 306.69 Kb.

RESUMEN

La polimiositis es una enfermedad inflamatoria, de origen presumiblemente inmunitario y que, en ocasiones, se asocia con otras enfermedades de la colágena. Se comenta el caso de una mujer de 48 años de edad que acudió para valoración por debilidad muscular y dolor en las cuatro extremidades. Se le realizaron estudios de serología y biopsia muscular para el diagnostico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Sthepen J, Di Martino, Lawrence JK. Newer therapeutic approaches: inflammatory muscle disorders. Rheum Dis Clin N Am 2006;32:121-28.

2. Frank L, Mastaglia B, Phillips A. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am 2002;28:723-41.

3. Choy EHS, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology 2002;41:7-13.

4. Meulen MFG, Bronner IM, Hoogendijk JE, et al. Polymyositis an overdiagnosed entity. Neurology 2003;61:316-21.

5. Nizar Chahin, Andrew GE. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008;70:418-24.

6. Robert L. Wortmann, Salvatore DiMauro. Differentiating idiopathic inflammatory myopathies from metabolic myopathies. Rheum Dis Clin N Am 2002;28:759-78.

7. Namieta M. Janssen, Dilip R. Karnad, et al. Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 2002;18:729-48.

8. Steven A. Greenberg. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007;69:2008-19.

9. Dalakas M. Treatment of polymyositis and dermatomyositis. Curr Opin Rheumatol 1989;1:443-9.

10. Ansell BM. Management of polymyositis and dermatomyositis. Clin Rheum Dis 1984; 10:205-13.

11. Ng YT, Ouvrier RA, Wu T. Drug therapy in juvenile dermatomyositis: Follow up study. J Child Neurol 1998;13:109-12.

12. Ramirez G, Asherson RA, Khamashta MA, et al. Adult onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. Semin Arthritis Rheum 1990;20:114-20.

13. Bunch TW. Prednisone and azathioprine for polymyositis: long term follow up. Arthritis Rheum 1981;24:45-8.

14. Joffe MM, Love LA, Leff RL, et al. Drug therapy of idiopathic inflammatory myopathies: Predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy. Am J Med 1993;94:379-87.

15. Villalba L, Hicks JE, Adams EM, et al. Treatment of refractory myositis: a randomized crossover study of two new citotoxic regimens. Arthritis Rheum 1998;41:392-9.

16. Zieglschmid-Adams ME, Pandya A, Cohen, et al. The Value of methotrexate in dermatomyositis. J Am Acad Dermatol 1998;38:130-2.

17. Malaviya AN, Many A, Schwartz RS. Treatment of dermatomyositis with methotrexate. Lancet 1968;2:485-8.

18. Sinoway PA, Callen JP. Chlorambucil. An effective corticosteroid- sparing agent for patients with recalcitrant dermatomyositis. Arthritis Rheum 1993;36:319-24.

19. Gelfand EW. The use of intravenous immune globulin in collagen vascular disorders: a potentially new modality of therapy. J Allergy Clin Immunol 1989;84:613-5.